术前炎症标志物评估肝细胞癌手术预后价值的研究进展

摘要/Abstract

摘要： 肝细胞癌是典型的恶性肿瘤。随着医疗技术的进步,肝癌的早期诊断及个性化治疗取得了大量进展。但肝癌患者手术治疗后,临床预后仍不佳且复发率高。因此,在肝癌患者中识别准确敏感的临床预后参数十分重要。中性粒细胞、淋巴细胞、纤维蛋白原等生物学指标不仅反映机体炎症,也可将其联合使用来预测肝癌手术患者的预后和肿瘤复发率。这其中包括中性粒细胞/淋巴细胞、血小板/淋巴细胞、纤维蛋白原、预后营养指数、控制营养状态评分、天冬氨酸转氨酶/血小板计数及天冬氨酸转氨酶/中性粒细胞等。本文就上述炎症标志物对肝细胞癌手术患者预后价值的研究进展进行综述。

关键词: 肝细胞癌, 炎症标志物, 肿瘤复发, 预后

彭国庆, 王小梅, 王瑞, 余欢, 王思涵. 术前炎症标志物评估肝细胞癌手术预后价值的研究进展[J]. 肝脏, 2023, 28(9): 1123-1126.

参考文献

[1] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版). 中华肝脏病杂志, 2022,30(04):367-388.
[2] Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int, 2017,11(4):317-370.
[3] 秦硕, 李春梅, 李冉, 等. 术前外周血炎症指标对舌鳞状细胞癌预后预测价值的分析. 华西口腔医学杂志, 2022,40(3):335-340.
[4] Swierczak A, Mouchemore KA, Hamilton JA, et al. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev, 2015,34(4):735-751.
[5] 何玲华, 陈刚, 佟虹兴, 等. 肿瘤相关中性粒细胞在肝细胞癌中的作用研究进展. 中国普外基础与临床杂志, 2022,29(8):1109-1114.
[6] Nagai S, Abouljoud MS, Kazimi M, et al. Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation. Transplantation, 2014,97(6):694-701.
[7] Liang L, Zhu J, Jia H, et al. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy. Oncotarget, 2016,7(1):1014-1028.
[8] 任家书, 马秀现, 李健, 等. 术前中性粒细胞/淋巴细胞比值对小肝癌患者并发微血管浸润的预测价值. 中国普通外科杂志, 2018,27(7):840-846.
[9] 吴美龙, 杨世忠, 冯晓彬, 等. 肝细胞癌术前炎症指标的预后价值. 中华消化外科杂志, 2021,20(2):213-219.
[10] Rich NE, Parvathaneni A, Sen A, et al. High neutrophil-lymphocyte ratio and delta neutrophil-lymphocyte ratio are associated with increased mortality in patients with hepatocellular cancer. Dig Dis Sci, 2021, 67(6):2666-2676.
[11] Johnson PJ, Dhanaraj S, Berhane S, et al. The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Br J Cancer, 2021,125(5):714-716.
[12] Miao S, Lu M, Liu Y, et al. Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis. Mol Oncol, 2020,14(10):2546-2559.
[13] Ma W, Zhang P, Qi J, et al. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. Sci Rep, 2016,6:35378.
[14] Yang Y, Wang MC, Tian T, et al. A high preoperative platelet-lymphocyte ratio is a negative predictor of survival after liver resection for hepatitis b virus-related hepatocellular carcinoma: a retrospective study. Front Oncol, 2020,10:576205.
[15] Kabir T, Noor NM, Junnarkar SP, et al. Does preoperative platelet-lymphocyte ratio or prognostic nutritional index predict survival after surgical resection for hepatocellular carcinoma?. HPB, 2016,18:e709-e710.
[16] Zhao Y, Si G, Zhu F, et al. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget, 2017,8(14):22854-22862.
[17] 林联库, 刘红枝, 黄霆峰, 等. 术前纤维蛋白原水平对肝细胞癌微血管侵犯及预后的影响. 肝胆胰外科杂志, 2021,33(8):454-459.
[18] Zhu WL, Fan BL, Liu DL, et al. Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma. Anticancer Res, 2009,29(7):2531-2534.
[19] Dai T, Deng M, Ye L, et al. Nomograms based on clinicopathological factors and inflammatory indicators for prediction of early and late recurrence of hepatocellular carcinoma after surgical resection for patients with chronic hepatitis B. Ann Transl Med, 2021,9(1):12.
[20] Kong W, Xu H, Cheng J, et al. The prognostic role of a combined fibrinogen and neutrophil-to-lymphocyte ratio score in patients with resectable hepatocellular carcinoma: a retrospective study. Med Sci Monit, 2020,26:e918824.
[21] Kosovali BD, Kucuk B, Balkiz SO, et al. Can prognostic nutritional index predict mortality in intensive care patients with COVID-19? Int J Clin Pract, 2021,75(11):e14800.
[22] Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi, 1984,85(9):1001-1005.
[23] Wang Z, Wang J, Wang P. The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: a meta-analysis of observational studies. PLoS One, 2018,13(10):e202987.
[24] Ji F, Liang Y, Fu S, et al. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy. HPB (Oxford), 2017,19(8):695-705.
[25] 王少虎, 曹毅, 张浩洋, 等. 中性粒细胞与淋巴细胞比值和预后营养指数对乙肝相关性肝癌切除的预后意义. 中华普通外科杂志, 2017,32(5):433-437.
[26] Ignacio DUJ, Gonzalez-Madrono A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp, 2005,20(1):38-45.
[27] Kuroda D, Sawayama H, Kurashige J, et al. Controlling nutritional status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer, 2018,21(2):204-212.
[28] Tokunaga R, Sakamoto Y, Nakagawa S, et al. CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection. Int J Colorectal Dis, 2017,32(1):99-106.
[29] Harimoto N, Yoshizumi T, Inokuchi S, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma: a multi-institutional study. Ann Surg Oncol, 2018,25(11):3316-3323.
[30] Takagi K, Domagala P, Polak WG, et al. Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. BMC Gastroenterol, 2019,19(1):211.
[31] Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology, 2007,46(3):912-921.
[32] Shen SL, Fu SJ, Chen B, et al. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection. Ann Surg Oncol, 2014,21(12):3802-3809.
[33] 张孝盈, 钱静, 李萍, 等. 无创方法诊断慢性乙型肝炎病毒携带者肝纤维化的临床价值. 中华肝脏病杂志, 2018,26(05):332-336.
[34] Lee J, Kim MY, Kang SH, et al. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci, 2018,75(3):128-132.
[35] 孙波. 预后营养指数联合天冬氨酸转氨酶/血小板比值评价肝癌患者肝切除术后预后的价值. 西南医科大学, 2021.
[36] Maegawa FB, Shehorn L, Aziz H, et al. Association between noninvasive fibrosis markers and postoperative mortality after hepatectomy for hepatocellular carcinoma. JAMA Netw Open, 2019,2(1):e187142.
[37] Liu Y, Wang ZX, Cao Y, et al. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int, 2016,15(3):266-274.
[38] Ji F, Fu S, Guo Z, et al. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Oncotarget, 2016,7(44):72276-72289.
[39] 邹伟婕, 陈立, 黄学卿, 等. 天冬氨酸转氨酶与中性粒细胞比值对肝癌患者TACE治疗预后的影响. 介入放射学杂志, 2017,26(8):705-711.
[40] Liu L, Wang W, Zhang Y, et al. Declined preoperative aspartate aminotransferase to neutrophil ratio index predicts poor prognosis in patients with intrahepatic cholangiocarcinoma after hepatectomy. Cancer Res Treat, 2018,50(2):538-550.